Unveiling Novel Approaches to Expanding Tumor- Reactive T-Cells & Reducing Bystander T-Cells
Time: 2:30 pm
day: Conference Day One - Track B - PM
Details:
- Sorting CD8 TIL for CD39 and CD103 prior to expansion enhances for tumor reactivity
- This selected expanded TIL has clinical activity in late-stage cancer patients
